NICOTINAMIDE ADENINE DINUCLEOTIDE 1G & TIRZEPATIDE'S SUCCESSOR : A BRITISH UPDATE

The emerging interest in NAD+ supplementation, particularly at a significant dosage of one gram, continues to build within the UK healthcare community. Concurrently, attention is focused on Retatrutide, a novel GLP-1 medication being viewed by many as a potential successor to Tirzepatide. At pres